Forward Pharma loses appeal in Tecfidera patent dispute with Biogen

Forward Pharma loses appeal in Tecfidera patent dispute with Biogen


REUTERS: A U.S. appeals court on Wednesday upheld a ruling that patents owned by Biogen Inc covering its blockbuster multiple sclerosis drug Tecfidera are valid, rejecting a challenge by Danish drugmaker Forward Pharma A/S.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога